DOACs – whom for? Secondary data analysis of current prescription trends

Autor:	Eichler, U, Selke, GW, Langner, I
Jazyk:	angličtina
Rok vydání:	2015
Předmět:	ddc: 610 610 Medical sciences Medicine health care economics and organizations
Zdroj:	22. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie; 20151203-20151204; Dresden; DOC15gaa05 /20151209/
DOI:	10.3205/15gaa05
Popis:	Background: In 2014, the cost for antithrombotic drugs reimbursed by German health care funds rose by 22% to 1.4 bill. Euros [ref:1]. This increase is mainly due to the continuing rise in prescriptions of direct oral anti-coagulants (DOACs), whose superiority to the older vitamin K[for full text, please go to the a.m. URL] 22. Jahrestagung der Gesellschaft für Arzneimittelanwendungsforschung und Arzneimittelepidemiologie
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8846d068d4a33cdbffdf55d0312c7a93 Zobrazit plný text záznamu